Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

An open study for a 2-year period to confirm the safety and immunogenicity of the candidate malaria vaccine RTS,S/AS02A in Mozambican children aged 1 to 4 years at the time of first vaccine dose.
SB257049
104297
NCT00323622
Malaria
Phase 2
 
This is a follow up study to 257049/026. The analysis-ready data from this study is provided in combined datasets with the analysis-ready data from 257049/026. An annotated case report form is not available for this study. A blank case report form will be provided.
July 2014

Powered by ideaPoint, Inc.